methylselenic acid has been researched along with Cancer of Endometrium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Dhaheri, M; Dong, Y; Ip, C; Jones, FE; Rowan, BG; Shah, YM | 1 |
1 other study(ies) available for methylselenic acid and Cancer of Endometrium
| Article | Year |
|---|---|
Selenium disrupts estrogen receptor (alpha) signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Endometrial Neoplasms; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Gene Expression; Humans; Neoplasms, Hormone-Dependent; Organoselenium Compounds; Proto-Oncogene Proteins c-myc; RNA, Messenger; Signal Transduction; Tamoxifen; Trefoil Factor-1; Tumor Suppressor Proteins | 2005 |